Unaffiliated Events

FDA Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP)

Advanced Manufacturing and Analytical Technologies (AMAT) for Regenerative Medicine Therapies (RMT) Workshop

Tuesday, March 14, 9:00 a.m.–4:45 p.m. ET

Virtual (Zoom)

From the organizer: The U.S. Food and Drug Administration (FDA) will host a virtual workshop for FDA staff and cellular and gene therapy stakeholders. The goal of the workshop is to obtain specialized knowledge from experts in the field of advanced manufacturing and analytical technologies (AMAT) for regenerative medicine therapies (RMT), discuss innovative manufacturing technologies and alternative testing methods, and share experiences, challenges, and best practices critical for chemistry, manufacturing, and controls (CMC) of RMT.

This workshop will be comprised of keynote speakers, presentations, and panel discussions with experts in the AMAT field.